ONCOPORE Trademark

Trademark Overview

On Wednesday, June 14, 2006, a trademark application was filed for ONCOPORE with the United States Patent and Trademark Office. The USPTO has given the ONCOPORE trademark a serial number of 78908494. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 24, 2019. This trademark is owned by Lytix Biopharma AS. The ONCOPORE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
oncopore

General Information

Serial Number78908494
Word MarkONCOPORE
Filing DateWednesday, June 14, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 24, 2019
Registration Number3520688
Registration DateTuesday, October 21, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLytix Biopharma AS
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTromso N-9294
NO
Party NameLytix Biopharma AS
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTromso N-9294
NO
Party NameLytix Biopharma AS
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTromso N-9294
NO

Trademark Events

Event DateEvent Description
Friday, May 24, 2019CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, October 21, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 24, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, April 24, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, April 23, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 21, 2015TEAS SECTION 8 RECEIVED
Tuesday, October 21, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, September 11, 20081(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, September 10, 2008NOTICE OF ALLOWANCE CANCELLED
Thursday, September 11, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 10, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 10, 2008TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, April 16, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2007NOTICE OF PUBLICATION
Tuesday, December 4, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 4, 2007ASSIGNED TO LIE
Monday, October 29, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 2, 2007TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 2, 2007EX PARTE APPEAL-INSTITUTED
Tuesday, October 2, 2007JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 2, 2007EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, April 3, 2007FINAL REFUSAL E-MAILED
Tuesday, April 3, 2007FINAL REFUSAL WRITTEN
Thursday, March 29, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, March 15, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 15, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2006NON-FINAL ACTION E-MAILED
Monday, November 20, 2006NON-FINAL ACTION WRITTEN
Wednesday, November 15, 2006ASSIGNED TO EXAMINER
Tuesday, June 20, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncopore cancer treatment preparations pharmaceutical